VU 0365114

CAS No. 1208222-39-2

VU 0365114( —— )

Catalog No. M26505 CAS No. 1208222-39-2

VU 0365114 is a positive allosteric modulator of mAChR M5 and increases ACh-induced calcium mobilization(EC50: 2.7 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 Get Quote
5MG 80 Get Quote
10MG 113 Get Quote
25MG 209 Get Quote
50MG 353 Get Quote
100MG 530 Get Quote
500MG 1152 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    VU 0365114
  • Note
    Research use only, not for human use.
  • Brief Description
    VU 0365114 is a positive allosteric modulator of mAChR M5 and increases ACh-induced calcium mobilization(EC50: 2.7 μM).
  • Description
    VU 0365114 is a positive allosteric modulator of mAChR M5 and increases ACh-induced calcium mobilization(EC50: 2.7 μM).
  • In Vitro
    VU 0365114 (10 μM) increases insulin secretion stimulated by ACh in human β-cells.VU 0365114 (10 μM) does not alter somatostatin secretion stimulated by ACh in human β-cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    Cleavable
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1208222-39-2
  • Formula Weight
    397.353
  • Molecular Formula
    C22H14F3NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 77.5 mg/mL (195.04 m)
  • SMILES
    FC(F)(F)Oc1ccc2N(Cc3ccc(cc3)-c3ccccc3)C(=O)C(=O)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
molnova catalog
related products
  • SCH-900271

    SCH-900271 is a potent nicotinic acid receptor for the treatment of dyslipidaemia and is commonly used in the study of mixed hyperlipidaemia and primary hypercholesterolaemia.

  • Tazomeline

    Tazomeline is a muscarinic M1 receptor agonist with neuroprotective activity.

  • Otenzepad

    Otenzepad is a selective antagonist of M2 mAChR with IC50s of 386 nM and 640 nM for rat heart and rabbit peripheral lung.